Article A2533
Author(s): Jace D. Johnny, DNP, APRN, AGACNP-BC, OCN, CCRN, Jeana Escobar, BSN, RN, CCRN, Ray Van Cao, BSN, RN, CCRN, Martin Cheehong Chow, BSN, RN, CCRN, Henry Van Slooten, BSN, RN, and Zachary Drury, DNP, APRN, AGACNP-BC, OCN, CCRN
Contact Hours 1.00
CERP A 1.00
Expires Mar 01, 2028
Topics: Pulmonary
Population: Adult
Role: APRN, Staff
Required reading for all learners: Implicit Bias impacts patient outcomes
This scoping review is focused on exploring the risk representation in the literature for acutely ill adult patients receiving the high-flow nasal cannula (HFNC) therapy. In addition, it identified common terms used in the literature regarding the concept of deterioration for patients with HFNC.Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.
AccreditationAmerican Association of Critical-Care Nurses is accredited as a provider of
nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for
{contactHours} contact hours.
The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.
Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.
Refund PolicyContinuing Education Activities are nonrefundable.